Key result
Low-intensity anticoagulation cuts bleeding ~62% vs high-intensity after On-X mechanical aortic valve replacement.
Why the study?
The study was conducted to explore the safety and efficacy of low-intensity anticoagulation in patients after On-X mechanical aortic valve replacement.
Does low-intensity anticoagulation (INR 1.5-2.0) reduce bleeding events without increasing embolic risk compared to high-intensity anticoagulation (INR 2.0-2.5) in patients after On-X mechanical aortic valve replacement?
RCT (n=104)
Randomly assigned
No
Does low-intensity anticoagulation (INR 1.5-2.0) reduce bleeding events without increasing embolic risk compared to high-intensity anticoagulation (INR 2.0-2.5) in patients after On-X mechanical aortic valve replacement?
Low-intensity anticoagulation (target INR 1.5-2.0) after On-X mechanical aortic valve replacement reduces bleeding events without increasing thromboembolic risk compared to standard intensity.
Answers are grounded in this paper and cite their sources.
Supports low-intensity anticoagulation after On-X AVR to cut bleeding; challenges conventional high-intensity targets.
OBJECTIVE: To explore the safety and efficacy of low-intensity anticoagulation in patients after On-X mechanical aortic valve replacement. METHODS: A total of 104 patients undergoing aortic valve replacement in Cardiac Surgery Department of Sichuan Provincial People's Hospital from December 2018 to December 2021 were randomly divided into low-intensity anticoagulant (INR:1.5-2.0) and high-intensity anticoagulant (INR:2.0-2.5) to compare the incidence of adverse events related to postoperative anticoagulation between the two groups. RESULTS: Fifty-three patients were included in the low-intensity anticoagulation group (INR 1.5-2.0), and 51 patients were included in the high-intensity group (2.0-2.5). There was no significant difference in baseline data and surgical index between the two groups (P > 0.05); there were statistically significant differences in PT, INR and bleeding events (P < 0.05), but no significant difference in embolic events (P > 0.05). CONCLUSION: For patients requiring On-X mechanical aortic valve replacement who have no risk factors for thromboembolism, it is appropriate to control the INR in the target range 1.5-2.0, which can reduce the incidence of bleeding adverse events and significantly improve the quality of life, without increasing the risk of thromboembolic adverse events.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) conducted an RCT in Aortic valve disease requiring On-X mechanical aortic valve replacement (n=104). Low-intensity anticoagulation (warfarin) vs. High-intensity anticoagulation (target INR 2.0-2.5) was evaluated on Total bleeding events (p=0.022). Low-intensity anticoagulation reduced total bleeding events to with high-intensity anticoagulation after On-X mechanical aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: